July 12 management tracks: Linus Lin joins Lilly’s Chorus; plus Ocular, Aptinyx

Eli Lilly and Co. (NYSE:LLY) named Linus Lin managing director of its Chorus R&D unit. He was previously VP and head of Lilly China Innovation and Partnerships.

Eye disease company Ocular Therapeutix Inc. (NASDAQ:OCUL) hired Christopher White as SVP, head of business and corporate development. He was COO at Silver Creek Pharmaceuticals Inc. (San Francisco, Calif.)...